Mario Venditti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem. A case report	EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES	2022
High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii	ANTIBIOTICS	2022
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature	NEW MICROBIOLOGICA	2022
Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections in Patients With Liver Cirrhosis	JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY	2022
THE ADA (AGE-D-DIMER-ALBUMIN) SCORE TO PREDICT THROMBOSIS IN SARS-CoV-2	THROMBOSIS AND HAEMOSTASIS	2022
An outbreak sustained by ST15 Klebsiella pneumoniae carrying 16S rRNA methyltransferases and blaNDM: evaluation of the global dissemination of these resistance determinants	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS	2022
Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared	ANTIBIOTICS	2022
Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study	INFECTION	2022
Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe Trauma	PATHOGENS	2022
Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae. Results from a multicentre retrospective study	JAC-ANTIMICROBIAL RESISTANCE	2022
Compassionate use of meropenem/vaborbactam for infections caused by kpc-producing Klebsiella pneumoniae. A multicentre study	JAC-ANTIMICROBIAL RESISTANCE	2022
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study (Infection, (2022), 50, 5, (1373-1382), 10.1007/s15010-022-01869-w)	INFECTION	2022
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study	FRONTIERS IN NUTRITION	2021
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection	DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE	2021
The role of teicoplanin in the treatment of SARS-CoV-2 infection: a retrospective study in critically ill COVID-19 patients (Tei-COVID Study)	JOURNAL OF MEDICAL VIROLOGY	2021
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study	FRONTIERS IN NUTRITION	2021
Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION	2021
Procalcitonin in daily clinical practice: an evergreen tool also during a pandemic	INTERNAL AND EMERGENCY MEDICINE	2021
Effect of n-acetylcysteine administration on 30-day mortality in critically ill patients with septic shock caused by carbapenem-resistant klebsiella pneumoniae and acinetobacter baumannii: A retrospective case-control study	ANTIBIOTICS	2021
Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission	INFECTION	2021